MAPT and Alzheimer disease: As an endpoint, the tau protein, a fundamental feature of Alzheimer’s disease, aggravates brain tissue damage in transient experimental brain ischemia through tau protein excitotoxicity (Figure 2) [63,88] and tau protein-mediated iron export [89].